My current research focuses on examining the phenotypic (anatomic, physiologic, and clinical) heterogeneity among patients with hypertrophic cardiomyopathy (HCM) and their family members, including genotype-phenotype relationships that may account for this heterogeneity, novel diagnostic methods to diagnose at risk individuals before clinically manifest disease, and on the effect of therapeutic interventions on coronary and myocardial physiology in patients with severe obstructive HCM. Research is also directed at management and outcomes of patients with coronary artery disease (CAD) and acute coronary syndromes.

Interventional cardiology, coronary angioplasty, atherectomy and stenting, valvuloplasty, peripheral intervention, percutaneous atrial septal defect closure, transcoronary alcohol septal ablation for HCM, cardiac catheterization, hypertrophic cardiomyopathy with obstruction, coronary ultrasonographic and physiologic assessment, cardiac critical care

• Information for Patients